These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 4154378

  • 1. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE, Custy J, Steen RG, Newman WH.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H, Lahovaara S, Mattila MJ.
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract] [Full Text] [Related]

  • 3. Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
    Somani P, Kumakura S.
    Recent Adv Stud Cardiac Struct Metab; 1973 Mar; 3():367-85. PubMed ID: 4806661
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P, Zemanová M, Csöllei J, Racanská E, Tumová I.
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR, Boyles SM.
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract] [Full Text] [Related]

  • 6. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK, Hardman HF.
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract] [Full Text] [Related]

  • 7. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS, Hutton I, Lawrie TD, Lorimer AR, Reid JM.
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [Abstract] [Full Text] [Related]

  • 8. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y, Nakao K, Kato H, Takagi K.
    Jpn J Pharmacol; 1974 May; 24(0):s:73. PubMed ID: 4151686
    [No Abstract] [Full Text] [Related]

  • 9. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS, March H, Vangrow JS, Cassidy J, Kern JC, Khemka M, Vawter M, Pagano J.
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of beta receptor blockaders on the atrioventricular stimulus conduction. Study by means of bundle of His electrocardiography].
    Halter J, Pfisterer M, Nager F.
    Schweiz Med Wochenschr; 1974 Nov 02; 104(44):1554-7. PubMed ID: 4153699
    [No Abstract] [Full Text] [Related]

  • 11. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T, Takano M, Tamura A, Kubota H, Suzuki N.
    Masui; 1970 May 02; 19(5):515-22. PubMed ID: 4393894
    [No Abstract] [Full Text] [Related]

  • 12. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A, Torchiana ML, Stavorski JM, Ludden CT, Minsker DH, Stone CA.
    Arch Int Pharmacodyn Ther; 1973 Sep 02; 205(1):76-93. PubMed ID: 4148410
    [No Abstract] [Full Text] [Related]

  • 13. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
    Evans DB, Peschka MT, Lee RJ, Laffan RJ.
    Eur J Pharmacol; 1976 Jan 02; 35(1):17-27. PubMed ID: 3420
    [Abstract] [Full Text] [Related]

  • 14. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR, Pullman LG, Scholfield PC.
    Br J Pharmacol; 1973 Nov 02; 49(3):560-3. PubMed ID: 4149697
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B.
    J Pharmacol Exp Ther; 1973 Jul 02; 186(1):123-33. PubMed ID: 4146700
    [No Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR, Barker JW, Dugan D, Fox J, Giardino E.
    Arch Int Pharmacodyn Ther; 1974 Jan 02; 207(1):28-43. PubMed ID: 4151048
    [No Abstract] [Full Text] [Related]

  • 17. Myocardial transmembrane potentials and adrenergic receptors.
    Somani P, Guse P, Toscano P, Bassett AL.
    Adv Myocardiol; 1980 Jan 02; 1():189-207. PubMed ID: 6248934
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K, Oshima T, Koike H.
    Jpn J Pharmacol; 1979 Dec 02; 29(6):935-45. PubMed ID: 44326
    [Abstract] [Full Text] [Related]

  • 19. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers.
    Arnsdorf MF.
    J Pharmacol Exp Ther; 1977 Jun 02; 201(3):689-700. PubMed ID: 577217
    [No Abstract] [Full Text] [Related]

  • 20. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM, Troy HH, Carroll MS, Doroshuk CM, Sullivan ME.
    J Cardiovasc Pharmacol; 1993 Apr 02; 21(4):647-55. PubMed ID: 7681912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.